Typhoid and Paratyphoid (Enteric) Fever

Tropical Infectious Diseases

Volumn , Issue , 2011, Pages 121-127

  Levine, Myron M ^a   Tapia, Milagritos D ^a   Zaidi, Anita K M ^b  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885144106     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3935-5.00016-1     Document Type: Chapter

References (147)

1. Stuart BM, Pullen RL Typhoid. Arch Intern Med 1946, 78:629.
2. Osler W Typhoid Fever. The Principles and Practice of Medicine 1892, 2. D Appleton, New York. W. Osler (Ed.).
3. Crump JA, Luby SP, Mintz ED The global burden of typhoid fever. Bull WHO 2004, 82(5):346.
4. Ochiai RL, Wang X, von SL, et al. Salmonella paratyphi A rates, Asia. Emerg Infect Dis 2005, 11(11):1764.
5. Karkey A, Aryjal A, Basnyat B, Baker S Kathmandu, Nepal: still an enteric fever capital of the world. J Infect Dev Ctries 2008, 2(6):461.
6. Gupta SK, Medalla F, Omondi MW, et al. Laboratory-based surveillance of paratyphoid fever in the United States: travel and antimicrobial resistance. Clin Infect Dis 2008, 46(11):1656.
7. Szu SC, Stone AL, Robbins JD, et al. Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals. J Exp Med 1987, 166:1510.
8. Verma N, Reeves P Identification and sequence of rfbS and rfbE, which determine antigenic specificity of group A and group D salmonellae. J Bacteriol 1989, 171(10):5694.
9. Levy H, Diallo S, Tennant SM, et al. A PCR method to identify Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B among Salmonella isolates from the blood of patients with clinical enteric fever. J Clin Microbiol 2008, 46(5):1861.
10. Woodward TE, Smadel JE, Ley HL, et al. Preliminary report on the beneficial effect of choloromycetin in the treatment of typhoid fever. Ann Intern Med 1948, 29:131.
11. Anderson ES The problem and implications of chloramphenicol resistance in the typhoid bacillus. J Hyg (Lond) 1975, 74:289.
12. Gilman RH, Terminel M, Levine MM, et al. Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever. J Infect Dis 1975, 132:630.
13. Butler T, Linh NN, Arnold K, Pollack M Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor. Lancet 1973, 2:983.
14. Goldstein FW, Chumpitaz JC, Guevara JM, et al. Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J Infect Dis 1986, 153:261.
15. Gupta A Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach. Pediatr Infect Dis 1994, 13:124.
16. Rowe B, Ward LR, Threlfall EJ Spread of multiresistant Salmonella typhi. Lancet 1990, 336:1065.
17. Bhutta ZA Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child 1996, 75:214.
18. Wain J, Hoa NT, Chinh NT, et al. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997, 25(6):1404.
19. Parkhill J, Dougan G, James KD, et al. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 2001, 413(6858):848.
20. Deng W, Liou SR, Plunkett G, et al. Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J Bacteriol 2003, 185(7):2330.
21. McClelland M, Sanderson KE, Clifton SW, et al. Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet 2004, 36(12):1268.
22. Edelman R, Levine MM Summary of an international workshop on typhoid fever. Rev Infect Dis 1986, 8:329.
23. Lin FY, Vo AH, Phan VB, et al. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg 2000, 62(5):644.
24. Ochiai RL, Acosta CJ, Novaro-Holliday, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull WHO 2008, 86(4):260.
25. Sinha A, Sazawal S, Kumar R, et al. Typhoid fever in children aged less than 5 years. Lancet 1999, 354(9180):734.
26. Brooks WA, Hossain A, Goswami D, et al. Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg Infect Dis 2005, 11(2):326.
27. Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998, 158(6):633.
28. Steinberg EB, Bishop R, Haber P, et al. Typhoid fever in travelers: who should be targeted for prevention?. Clin Infect Dis 2004, 39(2):186.
29. Lynch MF, Blanton EM, Bulens S, et al. Typhoid fever in the United States, 1999-2006. JAMA 2009, 302(8):859.
30. Medina E, Yrarrazaval M Fiebre tifoidea en Chile: consideraciones epidemiologicas. Rev Med Chile 1983, 111:609.
31. Ameh EA Typhoid ileal perforation in children: a scourge in developing countries. Ann Trop Paediatr 1999, 19(3):267.
32. Ugwu BT, Yiltok SJ, Kidmas AT, Opaluwa AS Typhoid intestinal perforation in north central Nigeria. West Afr J Med 2005, 24(1):1.
33. Levine MM, Black RE, Lanata C Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area. J Infect Dis 1982, 146:724.
34. Khatri NS, Maskey P, Poudel S, et al. Gallbladder carriage of Salmonella paratyphi A may be an important factor in the increasing incidence of this infection in South Asia. Ann Intern Med 2009, 150(8):567.
35. Farid Z Chronic urinary salmonella carriers with intermittent bacteraemia. J Egypt Public Health Assoc 1970, 45(1):157.
36. Levine MM, Taylor DN, Ferreccio C Typhoid vaccines come of age. Pediatr Infect Dis J 1989, 8:374.
37. Wolman A, Gorman A The Significance of Waterborne Typhoid Fever Outbreaks 1931, Williams & Wilkins, Baltimore.
38. Typhoid in the large cities of the United States in 1919. JAMA 1920, 672. Anonymous.
39. Lin FY, Becke JM, Groves C, et al. Restaurant-associated outbreak of typhoid fever in Maryland: identification of carrier facilitated by measurement of serum Vi antibodies. J Clin Microbiol 1988, 26(6):1194.
40. Soper GA The curious career of Typhoid Mary. Bull NY Acad Med 1939, 15:698.
41. Taylor JP, Shandera WX, Betz TG, et al. Typhoid fever in San Antonio, Texas: an outbreak traced to a continuing source. J Infect Dis 1984, 149(4):553.
42. Birkhead GS, Morse DL, Levine WC, et al. Typhoid fever at a resort hotel in New York: a large outbreak with an unusual vehicle. J Infect Dis 1993, 167:1228.
43. Olsen SJ, Bleasdale SC, Magnano AR, et al. Outbreaks of typhoid fever in the United States, 1960-99. Epidemiol Infect 2003, 130(1):13.
44. Mermin JH, Villar R, Carpenter J, et al. A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis 1999, 179(6):1416.
45. Egoz N, Shihab S, Leitner L, Lucian M An outbreak of typhoid fever due to contamination of the municipal water supply in northern Israel. Isr J Med Sci 1988, 24(11):640.
46. Walker W The Aberdeen typhoid outbreak of 1964. Scott Med J 1965, 10:466.
47. Yoon J, Segal-Maurer S, Rahal JJ An outbreak of domestically acquired typhoid fever in Queens, NY. Arch Intern Med 2004, 164(5):565.
48. Feldman RE, Baine WB, Nitzkin JL, et al. Epidemiology of Salmonella typhi infection in a migrant labor camp in Dade County, Florida. J Infect Dis 1974, 130:334.
49. Neumann AK, Dinbergs IK Typhoid and old lace, a grandmother carrier. Clin Pediatr (Phila) 1973, 12(5):288.
50. Blaser MJ, Hickman FW, Farmer JJ, Brenner DJ, Ballows A, Feldman RA Salmonella typhi: the laboratory as a reservoir of infection. J Infect Dis 1980, 142:934.
51. Blaser MJ, Lofgren JP Fatal salmonellosis originating in a clinical microbiology laboratory. J Clin Microbiol 1981, 13:855.
52. Dritz SK, Braff EH Sexually transmitted typhoid fever. N Engl J Med 1977, 296:1359.
53. Reller ME, Olsen SJ, Kressel AB, et al. Sexual transmission of typhoid fever: a multistate outbreak among men who have sex with men. Clin Infect Dis 2003, 37(1):141.
54. Lewis MD, Serichantalergs O, Pitarangsi C, et al. Typhoid fever: a massive, single-point source, multidrug-resistant outbreak in Nepal. Clin Infect Dis 2005, 40(4):554.
55. Kubota K, Barrett TJ, Ackers ML, Brachman PS, Mintz ED Analysis of Salmonella enterica serotype Typhi pulsed-field gel electrophoresis patterns associated with international travel. J Clin Microbiol 2005, 43(3):1205.
56. Le TA, Lejay-Collin M, Grimont PA, et al. Endemic, epidemic clone of Salmonella enterica serovar Typhi harboring a single multidrug-resistant plasmid in Vietnam between 1995 and 2002. J Clin Microbiol 2004, 42(7):3094.
57. Thong KL, Cheong YM, Puthucheary S, Koh CL, Pang T Epidemiologic analysis of sporadic Salmonella typhi isolates and those from outbreaks by pulsed-field gel electrophoresis. J Clin Microbiol 1994, 32(5):1135.
58. Octavia S, Lan R Single-nucleotide-polymorphism typing and genetic relationships of Salmonella enterica serovar Typhi isolates. J Clin Microbiol 2007, 45(11):3795.
59. Baker S, Holt K, van de Vosse E, et al. High-throughput genotyping of Salmonella enterica serovar Typhi allowing geographical assignment of haplotypes and pathotypes within an urban District of Jakarta, Indonesia. J Clin Microbiol 2008, 46(5):1741.
60. Vollaard AM, Ali S, Widjaja S, et al. Identification of typhoid fever and paratyphoid fever cases at presentation in outpatient clinics in Jakarta, Indonesia. Trans R Soc Trop Med Hyg 2005, 99(6):440.
61. Maskey AP, Day JN, Phung QT, et al. Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006, 42(9):1247.
62. Huckstep R Typhoid Fever and the Other Salmonella Infections 1962, E & S Livingstone, Edinburgh.
63. Hoffman T, Ruiz C, Counts G, et al. Waterborne typhoid fever in Dade County, Florida. Am J Med 1975, 59:481.
64. Gilman R, Terminel M, Levine M, et al. Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet 1975, 1:1211.
65. Hoffman S, Punjabi N, Kumala S, et al. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 1984, 310:82.
66. Ferreccio C, Levine MM, Manterola A, et al. Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years. J Pediatr 1984, 104:899.
67. Mahle WT, Levine MM Salmonella typhi infection in children younger than five years of age. Pediatr Infect Dis J 1993, 12:627.
68. Ames W, Robins M Age and sex as factors in the development of the typhoid carrier state and a method of estimating carrier prevalence. Am J Public Health 1943, 33:221.
69. Ledingham J, Arkwright J The Carrier Problem in Infectious Diseases 1912, Arnold, London.
70. Salas M, Angulo O, Villegus J Patologia de la fiebre tifoida en los ninos. Biol Med Hosp Mex 1960, 17:63.
71. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, Snyder MJ Typhoid fever: pathogenesis and immunologic control. N Engl J Med 1970, 283:686. 739.
72. Gaines S, Sprinz H, Tully J, Tigertt W Studies on infection and immunity in experimental typhoid fever. VII. The distribution of Salmonella typhi in chimpanzee tissue following oral challenge and the relationship between the numbers of bacilli and morphologic lesions. J Infect Dis 1968, 118:293.
73. Carter P, Collins R The route of enteric infection in normal mice. J Exp Med 1974, 139:1189.
74. Kohbata S, Yokoyama H, Yabuchi E Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: an ultrastructural study. Microbiol Immunol 1986, 30:1225.
75. Takeuchi A Electron microscope studies of experimental Salmonella infection. I. Penetrations into the intestinal epithelium by Salmonella typhimurium. Am J Pathol 1967, 50:109.
76. Kops SK, Lowe DK, Bement WM, West AB Migration of Salmonella typhi through intestinal epithelial monolayers: an in vitro study. Microbiol Immunol 1996, 40(11):799.
77. Robbins J, Robbins J Reexamination of the protective role of the capsular polysaccharide Vi antigen of Salmonella typhi. J Infect Dis 1984, 150:436.
78. Baker S, Sarwar Y, Aziz H, et al. Detection of Vi-negative Salmonella enterica serovar Typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan. J Clin Microbiol 2005, 43(9):4418.
79. Butler T, Bell WR, Levin J, et al. Typhoid fever: studies of blood coagulation, bacteremia and endotoxemia. Arch Intern Med 1978, 138:407.
80. Gilman RH, Young C, Bulger R, et al. Anatomical and immunological responses of rabbit gallbladders to bacterial infections. Infect Immun 1982, 36(1):407.
81. Avendano A, Herrera P, Horwitz I, et al. Duodenal string cultures. Practicality and sensitivity for diagnosing enteric fever in children. J Infect Dis 1986, 53:359.
82. Hoffman S, Punjabi N, Rockhill R, et al. Duodenal string-capsule culture compared with bone-marrow, blood and rectal swab cultures for diagnosing typhoid and paratyphoid fever. J Infect Dis 1984, 149:157.
83. Benavente L, Gotuzzo E, Guerra J, et al. Diagnosis of typhoid fever using a string capsule device. Trans R Soc Trop Med Hyg 1984, 78:404.
84. Levine MM, Black RE, Lanata C Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area. J Infect Dis 1982, 146:724. Chilean Typhoid Committee.
85. Merselis JG, Kaye D, Connolly CS, Hook WE Quantitative bacteriology of the typhoid carrier state. Am J Trop Med Hyg 1964, 13:425.
86. Dunstan SJ, Stephens HA, Blackwell JM, et al. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis 2001, 183(2):261.
87. Dunstan SJ, Hue NT, Rockett K, et al. A TNF region haplotype offers protection from typhoid fever in Vietnamese patients. Hum Genet 2007, 122(1):51.
88. Ali S, Vollaard AM, Widjaja S, et al. PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever. Clin Exp Immunol 2006, 144(3):425.
89. Losonsky GA, Ferreccio C, Kotloff KL, et al. Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers. J Clin Microbiol 1987, 25:2266.
90. Lanata CF, Levine MM, Ristori C, et al. Vi serology in detection of chronic Salmonella typhi carriers in an endemic area. Lancet 1983, 2:441.
91. Sztein MB Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica serovar Typhi strains used as live oral vaccines in humans. Clin Infect Dis 2007, 45(suppl 1):S15.
92. Guerra-Caceres J, Gotuzzo-Herencia E, Crosby-Dagnino E, et al. Diagnostic value of bone marrow culture in typhoid fever. Trans R Soc Trop Med Hyg 1979, 73:680.
93. Hickman-Brenner FW, Farmer JJ Bacteriophage types of Salmonella typhi in the United States from 1974 through 1981. J Clin Microbiol 1983, 17(1):172.
94. Song JH, Cho H, Park MY, et al. Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction. J Clin Microbiol 1993, 31:1439.
95. Ali A, Haque A, Haque A, et al. Multiplex PCR for differential diagnosis of emerging typhoidal pathogens directly from blood samples. Epidemiol Infect 2009, 137(1):102.
96. Zhu Q, Lim CK, Chan YN Detection of Salmonella typhi by polymerase chain reaction. J Appl Bacteriol 1996, 80:244.
97. Widal G, Sicard A Rescherches de la reaction agglutinate dans le sang et le serum desséchés des typhiques et dans la serosité des vesications. Bull Soc Med Paris (3rd ser) 1896, 13:681.
98. Levine MM, Grados O, Gilman RH, et al. Diagnostic value of the Widal test in areas endemic for typhoid fever. Am J Trop Med Hyg 1978, 27:795.
99. Levine MM, Black RE, Ferreccio C, et al. Interventions to Control Endemic Typhoid Fever: Field Studies in Santiago, Chile 1986, PAHO Copublication, Washington, DC, Series No. 1 37.
100. Hoffman S, Flanigan TP, Klaucke D, et al. The Widal slide agglutination test, a valuable rapid diagnostic test in typhoid fever patients at the infectious diseases hospital of Jakarta. Am J Epidemiol 1986, 123:869.
101. Olsen SJ, Pruckler J, Bibb W, et al. Evaluation of rapid diagnostic tests for typhoid fever. J Clin Microbiol 2004, 42(5):1885.
102. Jesudason MV, Sivakumar S Prospective evaluation of a rapid diagnostic test Typhidot for typhoid fever. Indian J Med Res 2006, 123(4):513.
103. Dutta S, Sur D, Manna B, et al. Evaluation of new-generation serologic tests for the diagnosis of typhoid fever: data from a community-based surveillance in Calcutta, India. Diagn Microbiol Infect Dis 2006, 56(4):359.
104. Rahman M, Siddique AK, Tam FC, et al. Rapid detection of early typhoid fever in endemic community children by the TUBEX O9-antibody test. Diagn Microbiol Infect Dis 2007, 58(3):275.
105. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002, 347(22):1770.
106. Thaver D, Zaidi AK, Critchley J, et al. A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis. BMJ 2009, 338:b1865.
107. Parry CM, Beeching NJ Treatment of enteric fever. BMJ 2009, 338:b1159.
108. Threlfall EJ, Fisher IS, Berghold C, et al. Trends in antimicrobial drug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe, 1999-2001. Int J Antimicrob Agents 2003, 22(5):487.
109. Parry CM, Ho VA, Phuong lT, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007, 51(3):819.
110. Dolecek C, Tran TP, Nguyen NR, et al. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS ONE 2008, 3(5):e2188.
111. Threlfall EJ, Day M, de Pinna E, et al. Drug-resistant enteric fever in the UK. Lancet 2006, 367(9522):1576.
112. Thaver D, Zaidi AK, Critchley JA, et al. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2008;(4):CD004530.
113. Acosta C, Albert MJ, et al. Background Document: The Diagnosis, Treatment, and Prevention of Typhoid Fever 2003, Department of Vaccines & Biologicals, World Health Organization, Geneva.
114. Pandit A, Arjyal A, Day JN, et al. An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever. PLoS ONE 2007, 2(6):e542.
115. Cao XT, Kneen R, Nguyen TA, et al. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group. Pediatr Infect Dis J 1999, 18(3):245.
116. Effa EE, Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2008;(4):CD006083.
117. Punjabi NH, Hoffman SL, Edman DC, et al. Treatment of severe typhoid fever in children with high dose dexamethasone. Pediatr Infect Dis J 1988, 7(8):598.
118. Germanier R, Furer E Isolation and characterization of gal E mutant Ty21a of Salmonella typhi: a candidate strain for a live oral typhoid vaccine. J Infect Dis 1975, 141:553.
119. Levine MM, Ferreccio C, Black RE, et al. Progress in vaccines against typhoid fever. Rev Infect Dis 1989, 11(suppl 3):S552.
120. Levine MM, Ferreccio C, Black RE, Germanier R Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet 1987, 1:1049. Chilean Typhoid Committee.
121. Black RE, Levine MM, Ferreccio C, et al. Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee. Vaccine 1990, 8:81.
122. Levine MM, Ferreccio C, Cryz S, Ortiz E Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet 1990, 336:891.
123. Simanjuntak C, Paleologo F, Punjabi N, et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet 1991, 338:1055.
124. Wahdan MH, Serie C, Germanier R, et al. A controlled field trial of live oral typhoid vaccine Ty21a. Bull WHO 1980, 58:469.
125. Wahdan MH, Serie C, Cerisier Y, et al. A controlled field trial of live Salmonella typhi strain Ty21a oral vaccine against typhoid: three year results. J Infect Dis 1982, 145:292.
126. Ferreccio C, Levine MM, Rodriguez H, Contreras R Comparative efficacy of two, three, or four doses of Ty21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area. J Infect Dis 1989, 159:766.
127. Levine MM, Ferreccio C, Abrego P, et al. Duration of efficacy of ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 1999, 17(suppl 2):S22.
128. Wong KH, Feeley JC, Northrup RS, Forlines ME Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals. Infect Immun 1974, 9:348.
129. Tacket CO, Ferreccio C, Robbins JB, et al. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J Infect Dis 1986, 154:342.
130. Klugman K, Gilbertson IT, Kornhoff HJ, et al. Protective activity of Vi polysaccharide vaccine against typhoid fever. Lancet 1987, 2:1165.
131. Acharya VI, Lowe CU, Thapa R, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med 1987, 317:1101.
132. Keitel WA, Bond NL, Zahradnik JM, et al. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine 1994, 12(3):195.
133. Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 1996, 14(5):435.
134. Yang HH, Wu CG, Xie GZ, et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull WHO 2001, 79(7):625.
135. Michel R, Garnotel E, Spiegel A, et al. Outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast. Eur J Epidemiol 2005, 20(7):635.
136. Sur D, Ochiai RL, Bhattacharya SK, et al. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med 2009, 361:335.
137. Hindle Z, Chatfield SN, Phillimore J, et al. Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect Immun 2002, 70(7):3457.
138. Kirkpatrick BD, McKenzie R, O'Neill JP, et al. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. Vaccine 2006, 24(2):116.
139. Kirkpatrick BD, Tenney KM, Larsson CJ, et al. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations. J Infect Dis 2005, 192(3):360.
140. Hohmann EL, Oletta CA, Killeen KP, Miller SI phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J Infect Dis 1996, 173:1408.
141. Tacket CO, Sztein MB, Losonsky GA, et al. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun 1997, 65:452.
142. Tacket CO, Sztein MB, Wasserman SS, et al. Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908- htrA in US volunteers. Infect Immun 2000, 68:1196.
143. Tacket CO, Pasetti MF, Sztein MB, et al. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. J Infect Dis 2004, 190(3):565.
144. Wang JY, Noriega FR, Galen JE, et al. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar Typhi oral vaccine strain CVD 909. Infect Immun 2000, 68:4647.
145. Kossaczka Z, Lin FY, Ho VA, et al. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun 1999, 67(11):5806.
146. Lin FYC, Ho VA, Khiem HB, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001, 344:1263.
147. Mai NL, Phan VB, Vo AH, et al. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. N Engl J Med 2003, 349(14):1390.